 | • レポートコード：MRC2Q12-19477 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、副鼻腔/アレルギー治療薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 副鼻腔/アレルギー治療薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 副鼻腔/アレルギー治療薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 副鼻腔/アレルギー治療薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの副鼻腔/アレルギー治療薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の副鼻腔/アレルギー治療薬の売上および2028年までの予測に焦点を当てています。 副鼻腔/アレルギー治療薬のグローバル主要企業には、Cardinal Health、GSK、Bayer、Boiron、Johnson & Johnson、Insight Pharmaceuticals、Chattem、Dr Reddy's、Epic Pharma、Aurobindo Pharma USA、B. F. Ascher & Co、Geri-Care Pharmaceuticals、Lannett、Major Pharmaceuticals、Camber Pharmaceuticals Inc、OHM Laboratories、Perrigo Pharmaceuticals、Pharmaceutical Associates、Precision Dose、Raritan Pharmaceuticals、Reliable 1 Laboratoires、Rising Pharmaceuticals、Sheffield Pharmaceuticals、Taro Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 副鼻腔/アレルギー治療薬市場は、タイプとアプリケーションによって区分されます。世界の副鼻腔/アレルギー治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 錠剤、スプレー、その他 【アプリケーション別セグメント】 病院、薬局、通販、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 副鼻腔/アレルギー治療薬製品概要 - タイプ別市場（錠剤、スプレー、その他） - アプリケーション別市場（病院、薬局、通販、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の副鼻腔/アレルギー治療薬販売量予測2017-2028 - 世界の副鼻腔/アレルギー治療薬売上予測2017-2028 - 副鼻腔/アレルギー治療薬の地域別販売量 - 副鼻腔/アレルギー治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別副鼻腔/アレルギー治療薬販売量 - 主要メーカー別副鼻腔/アレルギー治療薬売上 - 主要メーカー別副鼻腔/アレルギー治療薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（錠剤、スプレー、その他） - 副鼻腔/アレルギー治療薬のタイプ別販売量 - 副鼻腔/アレルギー治療薬のタイプ別売上 - 副鼻腔/アレルギー治療薬のタイプ別価格 ・アプリケーション別市場規模（病院、薬局、通販、その他） - 副鼻腔/アレルギー治療薬のアプリケーション別販売量 - 副鼻腔/アレルギー治療薬のアプリケーション別売上 - 副鼻腔/アレルギー治療薬のアプリケーション別価格 ・北米市場 - 北米の副鼻腔/アレルギー治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の副鼻腔/アレルギー治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの副鼻腔/アレルギー治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の副鼻腔/アレルギー治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の副鼻腔/アレルギー治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の副鼻腔/アレルギー治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の副鼻腔/アレルギー治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の副鼻腔/アレルギー治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの副鼻腔/アレルギー治療薬市場規模（タイプ別、アプリケーション別） - 主要国別の副鼻腔/アレルギー治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Cardinal Health、GSK、Bayer、Boiron、Johnson & Johnson、Insight Pharmaceuticals、Chattem、Dr Reddy's、Epic Pharma、Aurobindo Pharma USA、B. F. Ascher & Co、Geri-Care Pharmaceuticals、Lannett、Major Pharmaceuticals、Camber Pharmaceuticals Inc、OHM Laboratories、Perrigo Pharmaceuticals、Pharmaceutical Associates、Precision Dose、Raritan Pharmaceuticals、Reliable 1 Laboratoires、Rising Pharmaceuticals、Sheffield Pharmaceuticals、Taro Pharmaceutical ・産業チェーン及び販売チャネル分析 - 副鼻腔/アレルギー治療薬の産業チェーン分析 - 副鼻腔/アレルギー治療薬の原材料 - 副鼻腔/アレルギー治療薬の生産プロセス - 副鼻腔/アレルギー治療薬の販売及びマーケティング - 副鼻腔/アレルギー治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 副鼻腔/アレルギー治療薬の産業動向 - 副鼻腔/アレルギー治療薬のマーケットドライバー - 副鼻腔/アレルギー治療薬の課題 - 副鼻腔/アレルギー治療薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Sinus and Allergy Medications estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sinus and Allergy Medications is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sinus and Allergy Medications is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sinus and Allergy Medications is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Sinus and Allergy Medications include Cardinal Health, GSK, Bayer, Boiron, Johnson & Johnson, Insight Pharmaceuticals, Chattem, Dr Reddy’s and Epic Pharma, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sinus and Allergy Medications companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sinus and Allergy Medications market. Further, it explains the major drivers and regional dynamics of the global Sinus and Allergy Medications market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Cardinal Health
GSK
Bayer
Boiron
Johnson & Johnson
Insight Pharmaceuticals
Chattem
Dr Reddy’s
Epic Pharma
Aurobindo Pharma USA
B. F. Ascher & Co
Geri-Care Pharmaceuticals
Lannett
Major Pharmaceuticals
Camber Pharmaceuticals Inc
OHM Laboratories
Perrigo Pharmaceuticals
Pharmaceutical Associates
Precision Dose
Raritan Pharmaceuticals
Reliable 1 Laboratoires
Rising Pharmaceuticals
Sheffield Pharmaceuticals
Taro Pharmaceutical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Sinus and Allergy Medications Segment by Type
Tablets
Sprays
Others
Sinus and Allergy Medications Segment by Application
Hospital
Retail Pharmacy
Online Retail
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sinus and Allergy Medications market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sinus and Allergy Medications market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sinus and Allergy Medications, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Sinus and Allergy Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sinus and Allergy Medications revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Sinus and Allergy Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Sinus and Allergy Medications revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Cardinal Health, GSK, Bayer, Boiron, Johnson & Johnson, Insight Pharmaceuticals, Chattem, Dr Reddy’s and Epic Pharma, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Sinus and Allergy Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sinus and Allergy Medications companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sinus and Allergy Medications revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sinus and Allergy Medications Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Sprays
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sinus and Allergy Medications Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Online Retail
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sinus and Allergy Medications Market Perspective (2017-2028)
2.2 Sinus and Allergy Medications Growth Trends by Region
2.2.1 Sinus and Allergy Medications Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Sinus and Allergy Medications Historic Market Size by Region (2017-2022)
2.2.3 Sinus and Allergy Medications Forecasted Market Size by Region (2023-2028)
2.3 Sinus and Allergy Medications Market Dynamics
2.3.1 Sinus and Allergy Medications Industry Trends
2.3.2 Sinus and Allergy Medications Market Drivers
2.3.3 Sinus and Allergy Medications Market Challenges
2.3.4 Sinus and Allergy Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sinus and Allergy Medications Players by Revenue
3.1.1 Global Top Sinus and Allergy Medications Players by Revenue (2017-2022)
3.1.2 Global Sinus and Allergy Medications Revenue Market Share by Players (2017-2022)
3.2 Global Sinus and Allergy Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sinus and Allergy Medications Revenue
3.4 Global Sinus and Allergy Medications Market Concentration Ratio
3.4.1 Global Sinus and Allergy Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sinus and Allergy Medications Revenue in 2021
3.5 Sinus and Allergy Medications Key Players Head office and Area Served
3.6 Key Players Sinus and Allergy Medications Product Solution and Service
3.7 Date of Enter into Sinus and Allergy Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sinus and Allergy Medications Breakdown Data by Type
4.1 Global Sinus and Allergy Medications Historic Market Size by Type (2017-2022)
4.2 Global Sinus and Allergy Medications Forecasted Market Size by Type (2023-2028)
5 Sinus and Allergy Medications Breakdown Data by Application
5.1 Global Sinus and Allergy Medications Historic Market Size by Application (2017-2022)
5.2 Global Sinus and Allergy Medications Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Sinus and Allergy Medications Market Size (2017-2028)
6.2 North America Sinus and Allergy Medications Market Size by Type
6.2.1 North America Sinus and Allergy Medications Market Size by Type (2017-2022)
6.2.2 North America Sinus and Allergy Medications Market Size by Type (2023-2028)
6.2.3 North America Sinus and Allergy Medications Market Share by Type (2017-2028)
6.3 North America Sinus and Allergy Medications Market Size by Application
6.3.1 North America Sinus and Allergy Medications Market Size by Application (2017-2022)
6.3.2 North America Sinus and Allergy Medications Market Size by Application (2023-2028)
6.3.3 North America Sinus and Allergy Medications Market Share by Application (2017-2028)
6.4 North America Sinus and Allergy Medications Market Size by Country
6.4.1 North America Sinus and Allergy Medications Market Size by Country (2017-2022)
6.4.2 North America Sinus and Allergy Medications Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Sinus and Allergy Medications Market Size (2017-2028)
7.2 Europe Sinus and Allergy Medications Market Size by Type
7.2.1 Europe Sinus and Allergy Medications Market Size by Type (2017-2022)
7.2.2 Europe Sinus and Allergy Medications Market Size by Type (2023-2028)
7.2.3 Europe Sinus and Allergy Medications Market Share by Type (2017-2028)
7.3 Europe Sinus and Allergy Medications Market Size by Application
7.3.1 Europe Sinus and Allergy Medications Market Size by Application (2017-2022)
7.3.2 Europe Sinus and Allergy Medications Market Size by Application (2023-2028)
7.3.3 Europe Sinus and Allergy Medications Market Share by Application (2017-2028)
7.4 Europe Sinus and Allergy Medications Market Size by Country
7.4.1 Europe Sinus and Allergy Medications Market Size by Country (2017-2022)
7.4.2 Europe Sinus and Allergy Medications Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sinus and Allergy Medications Market Size (2017-2028)
8.2 Asia-Pacific Sinus and Allergy Medications Market Size by Type
8.2.1 Asia-Pacific Sinus and Allergy Medications Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Sinus and Allergy Medications Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Sinus and Allergy Medications Market Share by Type (2017-2028)
8.3 Asia-Pacific Sinus and Allergy Medications Market Size by Application
8.3.1 Asia-Pacific Sinus and Allergy Medications Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Sinus and Allergy Medications Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Sinus and Allergy Medications Market Share by Application (2017-2028)
8.4 Asia-Pacific Sinus and Allergy Medications Market Size by Region
8.4.1 Asia-Pacific Sinus and Allergy Medications Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Sinus and Allergy Medications Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sinus and Allergy Medications Market Size (2017-2028)
9.2 Latin America Sinus and Allergy Medications Market Size by Type
9.2.1 Latin America Sinus and Allergy Medications Market Size by Type (2017-2022)
9.2.2 Latin America Sinus and Allergy Medications Market Size by Type (2023-2028)
9.2.3 Latin America Sinus and Allergy Medications Market Share by Type (2017-2028)
9.3 Latin America Sinus and Allergy Medications Market Size by Application
9.3.1 Latin America Sinus and Allergy Medications Market Size by Application (2017-2022)
9.3.2 Latin America Sinus and Allergy Medications Market Size by Application (2023-2028)
9.3.3 Latin America Sinus and Allergy Medications Market Share by Application (2017-2028)
9.4 Latin America Sinus and Allergy Medications Market Size by Country
9.4.1 Latin America Sinus and Allergy Medications Market Size by Country (2017-2022)
9.4.2 Latin America Sinus and Allergy Medications Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sinus and Allergy Medications Market Size (2017-2028)
10.2 Middle East & Africa Sinus and Allergy Medications Market Size by Type
10.2.1 Middle East & Africa Sinus and Allergy Medications Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Sinus and Allergy Medications Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Sinus and Allergy Medications Market Share by Type (2017-2028)
10.3 Middle East & Africa Sinus and Allergy Medications Market Size by Application
10.3.1 Middle East & Africa Sinus and Allergy Medications Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Sinus and Allergy Medications Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Sinus and Allergy Medications Market Share by Application (2017-2028)
10.4 Middle East & Africa Sinus and Allergy Medications Market Size by Country
10.4.1 Middle East & Africa Sinus and Allergy Medications Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Sinus and Allergy Medications Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Sinus and Allergy Medications Introduction
11.1.4 Cardinal Health Revenue in Sinus and Allergy Medications Business (2017-2022)
11.1.5 Cardinal Health Recent Developments
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Sinus and Allergy Medications Introduction
11.2.4 GSK Revenue in Sinus and Allergy Medications Business (2017-2022)
11.2.5 GSK Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Sinus and Allergy Medications Introduction
11.3.4 Bayer Revenue in Sinus and Allergy Medications Business (2017-2022)
11.3.5 Bayer Recent Developments
11.4 Boiron
11.4.1 Boiron Company Details
11.4.2 Boiron Business Overview
11.4.3 Boiron Sinus and Allergy Medications Introduction
11.4.4 Boiron Revenue in Sinus and Allergy Medications Business (2017-2022)
11.4.5 Boiron Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Sinus and Allergy Medications Introduction
11.5.4 Johnson & Johnson Revenue in Sinus and Allergy Medications Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 Insight Pharmaceuticals
11.6.1 Insight Pharmaceuticals Company Details
11.6.2 Insight Pharmaceuticals Business Overview
11.6.3 Insight Pharmaceuticals Sinus and Allergy Medications Introduction
11.6.4 Insight Pharmaceuticals Revenue in Sinus and Allergy Medications Business (2017-2022)
11.6.5 Insight Pharmaceuticals Recent Developments
11.7 Chattem
11.7.1 Chattem Company Details
11.7.2 Chattem Business Overview
11.7.3 Chattem Sinus and Allergy Medications Introduction
11.7.4 Chattem Revenue in Sinus and Allergy Medications Business (2017-2022)
11.7.5 Chattem Recent Developments
11.8 Dr Reddy’s
11.8.1 Dr Reddy’s Company Details
11.8.2 Dr Reddy’s Business Overview
11.8.3 Dr Reddy’s Sinus and Allergy Medications Introduction
11.8.4 Dr Reddy’s Revenue in Sinus and Allergy Medications Business (2017-2022)
11.8.5 Dr Reddy’s Recent Developments
11.9 Epic Pharma
11.9.1 Epic Pharma Company Details
11.9.2 Epic Pharma Business Overview
11.9.3 Epic Pharma Sinus and Allergy Medications Introduction
11.9.4 Epic Pharma Revenue in Sinus and Allergy Medications Business (2017-2022)
11.9.5 Epic Pharma Recent Developments
11.10 Aurobindo Pharma USA
11.10.1 Aurobindo Pharma USA Company Details
11.10.2 Aurobindo Pharma USA Business Overview
11.10.3 Aurobindo Pharma USA Sinus and Allergy Medications Introduction
11.10.4 Aurobindo Pharma USA Revenue in Sinus and Allergy Medications Business (2017-2022)
11.10.5 Aurobindo Pharma USA Recent Developments
11.11 B. F. Ascher & Co
11.11.1 B. F. Ascher & Co Company Details
11.11.2 B. F. Ascher & Co Business Overview
11.11.3 B. F. Ascher & Co Sinus and Allergy Medications Introduction
11.11.4 B. F. Ascher & Co Revenue in Sinus and Allergy Medications Business (2017-2022)
11.11.5 B. F. Ascher & Co Recent Developments
11.12 Geri-Care Pharmaceuticals
11.12.1 Geri-Care Pharmaceuticals Company Details
11.12.2 Geri-Care Pharmaceuticals Business Overview
11.12.3 Geri-Care Pharmaceuticals Sinus and Allergy Medications Introduction
11.12.4 Geri-Care Pharmaceuticals Revenue in Sinus and Allergy Medications Business (2017-2022)
11.12.5 Geri-Care Pharmaceuticals Recent Developments
11.13 Lannett
11.13.1 Lannett Company Details
11.13.2 Lannett Business Overview
11.13.3 Lannett Sinus and Allergy Medications Introduction
11.13.4 Lannett Revenue in Sinus and Allergy Medications Business (2017-2022)
11.13.5 Lannett Recent Developments
11.14 Major Pharmaceuticals
11.14.1 Major Pharmaceuticals Company Details
11.14.2 Major Pharmaceuticals Business Overview
11.14.3 Major Pharmaceuticals Sinus and Allergy Medications Introduction
11.14.4 Major Pharmaceuticals Revenue in Sinus and Allergy Medications Business (2017-2022)
11.14.5 Major Pharmaceuticals Recent Developments
11.15 Camber Pharmaceuticals Inc
11.15.1 Camber Pharmaceuticals Inc Company Details
11.15.2 Camber Pharmaceuticals Inc Business Overview
11.15.3 Camber Pharmaceuticals Inc Sinus and Allergy Medications Introduction
11.15.4 Camber Pharmaceuticals Inc Revenue in Sinus and Allergy Medications Business (2017-2022)
11.15.5 Camber Pharmaceuticals Inc Recent Developments
11.16 OHM Laboratories
11.16.1 OHM Laboratories Company Details
11.16.2 OHM Laboratories Business Overview
11.16.3 OHM Laboratories Sinus and Allergy Medications Introduction
11.16.4 OHM Laboratories Revenue in Sinus and Allergy Medications Business (2017-2022)
11.16.5 OHM Laboratories Recent Developments
11.17 Perrigo Pharmaceuticals
11.17.1 Perrigo Pharmaceuticals Company Details
11.17.2 Perrigo Pharmaceuticals Business Overview
11.17.3 Perrigo Pharmaceuticals Sinus and Allergy Medications Introduction
11.17.4 Perrigo Pharmaceuticals Revenue in Sinus and Allergy Medications Business (2017-2022)
11.17.5 Perrigo Pharmaceuticals Recent Developments
11.18 Pharmaceutical Associates
11.18.1 Pharmaceutical Associates Company Details
11.18.2 Pharmaceutical Associates Business Overview
11.18.3 Pharmaceutical Associates Sinus and Allergy Medications Introduction
11.18.4 Pharmaceutical Associates Revenue in Sinus and Allergy Medications Business (2017-2022)
11.18.5 Pharmaceutical Associates Recent Developments
11.19 Precision Dose
11.19.1 Precision Dose Company Details
11.19.2 Precision Dose Business Overview
11.19.3 Precision Dose Sinus and Allergy Medications Introduction
11.19.4 Precision Dose Revenue in Sinus and Allergy Medications Business (2017-2022)
11.19.5 Precision Dose Recent Developments
11.20 Raritan Pharmaceuticals
11.20.1 Raritan Pharmaceuticals Company Details
11.20.2 Raritan Pharmaceuticals Business Overview
11.20.3 Raritan Pharmaceuticals Sinus and Allergy Medications Introduction
11.20.4 Raritan Pharmaceuticals Revenue in Sinus and Allergy Medications Business (2017-2022)
11.20.5 Raritan Pharmaceuticals Recent Developments
11.21 Reliable 1 Laboratoires
11.21.1 Reliable 1 Laboratoires Company Details
11.21.2 Reliable 1 Laboratoires Business Overview
11.21.3 Reliable 1 Laboratoires Sinus and Allergy Medications Introduction
11.21.4 Reliable 1 Laboratoires Revenue in Sinus and Allergy Medications Business (2017-2022)
11.21.5 Reliable 1 Laboratoires Recent Developments
11.22 Rising Pharmaceuticals
11.22.1 Rising Pharmaceuticals Company Details
11.22.2 Rising Pharmaceuticals Business Overview
11.22.3 Rising Pharmaceuticals Sinus and Allergy Medications Introduction
11.22.4 Rising Pharmaceuticals Revenue in Sinus and Allergy Medications Business (2017-2022)
11.22.5 Rising Pharmaceuticals Recent Developments
11.23 Sheffield Pharmaceuticals
11.23.1 Sheffield Pharmaceuticals Company Details
11.23.2 Sheffield Pharmaceuticals Business Overview
11.23.3 Sheffield Pharmaceuticals Sinus and Allergy Medications Introduction
11.23.4 Sheffield Pharmaceuticals Revenue in Sinus and Allergy Medications Business (2017-2022)
11.23.5 Sheffield Pharmaceuticals Recent Developments
11.24 Taro Pharmaceutical
11.24.1 Taro Pharmaceutical Company Details
11.24.2 Taro Pharmaceutical Business Overview
11.24.3 Taro Pharmaceutical Sinus and Allergy Medications Introduction
11.24.4 Taro Pharmaceutical Revenue in Sinus and Allergy Medications Business (2017-2022)
11.24.5 Taro Pharmaceutical Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer